Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 2745-2750, June 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodenner, D. L.
Right arrow Articles by Borch, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodenner, D. L.
Right arrow Articles by Borch, R. F.

Effect of Diethyldithiocarbamate on cis-Diamminedichloroplatinum(II)-induced Cytotoxicity, DNA Cross-Linking, and {gamma}-Glutamyl Transpeptidase Inhibition1

Donald L. Bodenner, Peter C. Dedon, Peter C. Keng and Richard F. Borch2

Departments of Pharmacology [D. L. B., P. C. D., R. F. B.] and Radiation Oncology [P. C. K.] and The Cancer Center, University of Rochester, Rochester, New York 14642

Diethyldithiocarbamate (DDTC) has been shown to protect against the toxicity of cis-diamminedichloroplatinum(II) (DDP) without inhibition of antitumor effect. We report here that DDTC is unreactive toward DDP complexes in which both chlorides have been replaced by guanine residues but removes platinum from a variety of other ligands, and that this difference in reactivity may provide the basis for the selective protection observed with DDTC. Platinum-DNA complexes were unreactive toward DDTC (10 mM, >4 h) when the platinum:base ratio r < 0.02. DDTC did not react with the 1:2 complex of DDP:guanosine but reacted rapidly with the 1:1 complex and with the 1:2 complexes of DDP:adenosine. Reaction of DDP with DDTC was second order with a rate constant k = 4.4 M-1 min-1 at 37°C, corresponding to a t1/2 = 150 min at [DDTC] = 1 mM. Treatment of L1210 cells with DDTC (0.5–1 mM) after exposure to DDP indicated that DDTC had no effect on cell kill if DDTC treatment was delayed for 1 h after DDP. The effect of DDTC on DDP-induced DNA interstrand cross-links was also examined in L1210 cells. Interstrand cross-links were decreased by ~50% when cells were treated with DDTC immediately after DDP; no change in DNA interstrand cross-links was observed when DDTC treatment occurred 3 h after DDP. A modified alkaline elution procedure was used to evaluate the effects of high concentrations of DDTC, thiourea, and cyanide on platinum:DNA cross-links from L1210 DNA. Exposure to DDTC (0.5 M, 4 h) did not alter interstrand cross-links, but both thiourea and cyanide caused extensive reversal of cross-links at concentrations as low as 10 and 1 mM, respectively. Both commercial and rat kidney brush border preparations of {gamma}-glutamyl transpeptidase were inhibited by exposure to 2 mM DDP; exposure of the inhibited enzyme to DDTC (1 or 10 mM) resulted in significant restoration of enzyme activity. These data indicate that DDTC has unique chemical specificity in its reactions with platinum complexes and that this specificity is ideal for application as a chemoprotective drug against cis-platinum toxicity.

1 Supported in part by Grants CA 22925, CA 34620, and CA 11198. Taken in part from the Ph.D. Thesis of D. L. B., University of Minnesota, December 1983.

2 To whom requests for reprints should be addressed.

Received 7/25/85. Revised 12/10/85. Accepted 1/24/86.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Sonnenbichler, F. Scalera, I. Sonnenbichler, and R. Weyhenmeyer
Stimulatory Effects of Silibinin and Silicristin from the Milk Thistle Silybum marianum on Kidney Cells
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1375 - 1383.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Potdevin, F. Courjault-Gautier, B. M. Du Sorbier, P. Ripoche, and H. J. Toutain
Role of Protein Thiols in Inhibition of Sodium-Coupled Glucose Uptake by Cisplatin in Renal Brush-Border Membrane Vesicles
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 142 - 150.
[Abstract] [Full Text]


Home page
Journal of Pharmacy PracticeHome page
L. E. Davis
Long-Term Complications of Antineoplastic Agents
Journal of Pharmacy Practice, January 1, 1991; 4(2): 131 - 150.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.